US Edition
News from endpoints.news
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top endpoints.news News
US Politics · United StatesThe Trump administration on Thursday launched TrumpRx, a website it says will help patients buy prescription drugs directly at a discounted rate at a time when health care and the cost of living are growing concerns for Americans.See the Story
Trump administration launches TrumpRx website for discounted drugs
56% Center coverage: 219 sources
Diet · United StatesOnline telehealth company Hims and Hers Health will start offering compounded copies of Novo Nordisk's new Wegovy weight-loss pill at an introductory price of $49 per month, the company said on Thursday, about $100 less than the brand name.See the Story
Hims launches $49 compounded copy of Wegovy weight-loss pill
57% Center coverage: 72 sources
Wall Street · United StatesFDA Cracks Down on Copycat Drug Market Amid Hims Controversy The U.S. Food and Drug Administration (FDA) is poised to clamp down on companies marketing unapproved drugs that mimic FDA-sanctioned products. Commissioner Marty Makary highlighted this concern following Hims and Hers Health's launch of a $49 compounded version of Novo Nordisk's new weight-loss pill, Wegovy.The announcement caused a 10% drop in Hims' stock during after-hours trading. …See the Story
Hims Shares Plunge After FDA Threatens Action on 'Illegal Copycat Drugs ...
60% Center coverage: 5 sources
